N-Power Medicine

N-Power Medicine

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.npowermedicine.com

Last Round

Strategic

Dec 30, 2024

Total Funding Raised

$85M

Company Overview

N-Power Medicine is a biotechnology company focused on accelerating oncology innovation by utilizing a network of community oncology centers to efficiently identify suitable patients for research studies, thereby facilitating faster clinical trials for pharmaceutical companies and researchers.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Subscription SaaS

AI Layer

Application

Keywords

clinical research platformoncology research networkexternal control armreal-world evidenceRWEclinical trial accelerationdecentralized clinical trialsDCTcommunity oncologyreal-world dataRWDEHR integrationsynthetic control armcontract research organizationCROprecision medicine platformpoint-of-care platformhuman-in-the-loop

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

N-Power Medicine Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

N-Power Medicine Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 30, 2024
Series BJul 1, 2024

Key People

Founding team and executive leadership

Mark Lee

CEO & Co-Founder

Founding Team

Joel Smith

Chief Financial Officer

Executive Team

N-Power Medicine Investors

Notable investors and investment history

InvestorRounds
Innovatus Capital PartnersStrategic
Merck Global Health Innovation FundStrategic, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2025

    Launched industry-first Prospective External Control Arm platform for oncology drug development.

  • May 19, 2025

    Generating revenue from a growing base of BioPharma customers.

N-Power Medicine Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

N-Power Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about N-Power Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range122
Year Founded2021
Last FundingDec 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.